Biotech | November 20, 2021
Oravax and Genomma JV to commercialise Covid-19 vaccine in Mexico and Latam
Premas Biotech is the developer of the technology for the Covid-19 vaccine and a shareholder in Oravax Medical
Premas Biotech is the developer of the technology for the Covid-19 vaccine and a shareholder in Oravax Medical
Betting big on talent, resources, and the ecosystem required for innovation and enterprise, Prime Minister Narendra Modi invited stakeholders to ideate in India, innovate in India and Make in India for the world
Aster DM Healthcare announced its financial results for the quarter ended September 30, 2021
The ground-breaking project, led by Genomics England and NHS England, was established in 2013 to sequence 100,000 whole genomes from NHS patients and their families
The company will provide the technical and financial resources to support the study
_256_384.jpg)
Both parties are expected to invest a total of US $ 1 million to establish the brand
Gini Health works in the domain of personalised healthcare
This capability programme aims to upskill 5000 nurses across the country in the next year by converting the current modules into an e-learning one
It answers the most basic questions from a patient’s perspective
A total of Rs 17,691.08 cr. invested in 157 new approved medical colleges since 2014
Subscribe To Our Newsletter & Stay Updated
